SouthState Corp’s Helus Pharma Inc. Common Stock HELP Stock Holding History

SouthState Corp’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-145	Closed	-$7K	–	717
2021 Q4	$7K	Buy	+145	New	+$9.19K	﹤0.01%	598

Other funds holding HELP

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

PCC

Perry Creek Capital New York $218M AUM 18.4% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCWP Beachwood, Ohio $40.8M AUM 31.25% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SouthState Corp's HELP Position: Q1 2022 in Review

SouthState Corp sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2022, closing a stake of 145 shares — an estimated $7K sold.

SouthState Corp first reported a position in HELP in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 51 funds tracked by Wall St. Rank hold HELP as of Q1 2022.

SouthState Corp reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
SouthState Corp sold 145 Helus Pharma Inc. Common Stock shares in Q1 2022, an estimated $7K.
SouthState Corp first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and held it in 1 quarter.
SouthState Corp's Helus Pharma Inc. Common Stock position peaked at $7K in Q4 2021.
51 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2022.

Based on SouthState Corp's 13F filing for Q1 2022, filed 6 May 2022.